Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(S)-1-phenyl-2-propylamine
Desamfetamina
(S)-amphetamine
Dexamfetamine
(+)-α-methylphenethylamine
d-amphetamine
(S)-(+)-amphetamine
(S)-α-methylbenzeneethanamine
(+)-amphetamine
(+)-α-methylphenylethylamine
(αS)-α-methylbenzeneethanamine
Dexamfetamina
(S)-1-phenyl-2-aminopropane
Dexamfetaminum
Dextroamphetamine sulfate
(+)-(S)-amphetamine
Dexamphetamine
(S)-(+)-β-phenylisopropylamine
Dexanfetamina
Dextroamphetamine adipate
Dextroamphetamine saccharate
Dextroamphetamine
Brand Names
Mixed Salts of a Single-Entity Amphetamine Product
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
